Leukemia
A Phase 3b, Single-Arm, Multicenter Open-Label Study of Venetoclax in Combination with Azacitidine or Decitabine in an Outpatient Setting in AML Patients Ineligible for Intensive Chemotherapy (M19-072)
- Details
ClinicalTrials.gov ID:
NCT03941964
Diagnosis Type:
AML
USOR Number:
- Address
6545 France Avenue, Suite 210
Edina, MN 55435
P: (952) 928-2900